Details

Guidance Document: Tamper-resistance Formulations of Opioid Drug Products - Canada.ca

Metadata and links for an archived snapshot.

Source
Health Canada
Date
Jan 2, 2026 · edition #6
Timestamp
2026-01-02T08:10:23.480Z
Language
en
ID
432485
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview